Results 21 to 30 of about 255,147 (230)

Health Utility Weighting of the Modified Rankin Scale: A Systematic Review and Meta-analysis. [PDF]

JAMA Netw Open, 2020
This systematic review and meta-analysis characterizes the between-study variability in health utility weighting of the modified Rankin Scale in a population of patients with stroke and its implications when applied to the results of a clinical trial.
Rebchuk AD, O'Neill ZR, Szefer EK, Hill MD, Field TS.   +4 more
europepmc   +5 more sources

Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia [PDF]

Orphanet Journal of Rare Diseases, 2021
Background Approximately 10% of hereditary hemorrhagic telangiectasia (HHT) patients harbour brain vascular malformations (VMs). Intracranial hemorrhage (ICH) from brain VMs can lead to death or morbidity, while treatment options for brain VMs also have ...
K. P. Thompson, J. Nelson, H. Kim, S. M. Weinsheimer, D. A. Marchuk, M. T. Lawton, T. Krings, M. E. Faughnan, Brain Vascular Malformation Consortium HHT Investigator Group   +8 more
doaj   +8 more sources

Predicting 6-month modified Rankin Scale score in stroke patients [PDF]

Balneo and PRM Research Journal
The study aimed to identify predictors of 6-month outcomes in acute ischemic stroke (AIS) patients using the modified Rankin Scale (mRS). A prospective observational cohort study was conducted on 277 AIS patients admitted to the Neurology Departments of ...
Ioana Cristina Bârsan, Silvina Iluţ, Nicoleta Tohănean, Raluca Maria Pop, Ştefan Cristian Vesa, Lorena Ciumărnean, Antonia Eugenia Macarie, Lăcrămioara Perju-Dumbravă   +7 more
doaj   +3 more sources

Understanding the relationship between costs and the modified Rankin Scale: A systematic review, multidisciplinary consensus and recommendations for future studies. [PDF]

Eur Stroke J, 2017
Background and purpose Cost-of-illness studies often describe a single aggregate cost of a disease state. This approach is less helpful for a condition with a spectrum of outcomes like stroke.
Wilson A, Bath PM, Berge E, Cadilhac DA, Cuche M, Ford GA, Macisaac R, Quinn TJ, Taylor M, Walters M, Wolff C, Lees KR, for the ESO-VISTA Health Economics Working Group.   +12 more
europepmc   +4 more sources

Validity of the modified Rankin Scale in patients with aneurysmal subarachnoid hemorrhage: a randomized study [PDF]

BMC Neurology
Purpose The modified Rankin Scale (mRS), a clinician-reported outcome measure of global disability, has never been validated in patients with aneurysmal subarachnoid hemorrhage (aSAH).
E. Nobels-Janssen, E. N. Postma, I. L. Abma, J. M. C. van Dijk, I. R. de Ridder, H. Schenck, W. A. Moojen, M. H. den Hertog, D. Nanda, A. R. E. Potgieser, B. A. Coert, W. I. M. Verhagen, R. H. M. A. Bartels, P. J. van der Wees, D. Verbaan, H. D. Boogaarts   +15 more
doaj   +4 more sources

Patient centered outcomes in stroke: utility-weighted modified Rankin Scale results in a community-based study [PDF]

Frontiers in Neurology
Background and aimsThe transformation of modified Rankin Scale (mRS) scores based on the corresponding utilities of health-related quality of life questionnaires can facilitate the capture of Patient-Centered Outcomes (PCO) in stroke.
Carlos Delfino, Gabriel Cavada, Lorena Hoffmeister, Pablo Lavados, Pablo Lavados, Paula Muñoz Venturelli, Paula Muñoz Venturelli, Paula Muñoz Venturelli   +7 more
doaj   +4 more sources

Repeated Measures of Modified Rankin Scale Scores to Assess Functional Recovery From Stroke: AFFINITY Study Findings. [PDF]

J Am Heart Assoc, 2022
Background Function after acute stroke using the modified Rankin Scale (mRS) is usually assessed at a point in time. The analytical implications of serial mRS measurements to evaluate functional recovery over time is not completely understood. We compare
Chye A, Hackett ML, Hankey GJ, Lundström E, Almeida OP, Gommans J, Dennis M, Jan S, Mead GE, Ford AH, Beer CE, Flicker L, Delcourt C, Billot L, Anderson CS, Stibrant Sunnerhagen K, Yi Q, Bompoint S, Nguyen TH, Lung T.   +19 more
europepmc   +2 more sources

Association of Modified Rankin Scale With Recovery Phenotypes in Patients With Upper Extremity Weakness After Stroke. [PDF]

Neurology, 2022
Background and Objectives Precise measurement of outcomes is essential for stroke trials and clinical care. Prior research has highlighted conceptual differences between global outcome measures such as the modified Rankin Scale (mRS) and domain-specific ...
Erler KS, Wu R, DiCarlo JA, Petrilli MF, Gochyyev P, Hochberg LR, Kautz SA, Schwamm LH, Cramer SC, Finklestein SP, Lin DJ.   +10 more
europepmc   +2 more sources

The real-life reliability of the modified Rankin scale used in a stroke unit and a rehabilitation ward [PDF]

Advances in Psychiatry and Neurology
Natalia A. Pożarowszczyk, Iwona Kurkowska-Jastrzębska, Iwona M. Sarzyńska-Długosz, Maciej Nowak, Michał Karliński   +4 more
doaj   +3 more sources

Exploring the Reliability of the Modified Rankin Scale [PDF]

Stroke, 2009
Background and Purpose— The modified Rankin Scale (mRS) is the most prevalent outcome measure in stroke trials. Use of the mRS may be hampered by variability in grading. Previous estimates of the properties of the mRS have used diverse methodologies and may not apply to contemporary trial populations.
Terence J. Quinn, Jesse Dawson, Matthew R. Walters, Kennedy R. Lees   +3 more
openalex   +5 more sources